| Bahadur Shah, MD | |
|
2015 Jackson St, Anderson, IN 46016 | |
| (765) 649-2511 | |
| Not Available |
| Full Name | Bahadur Shah |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine |
| Experience | 36 Years |
| Location | 2015 Jackson St, Anderson, Indiana |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1912010547 | NPI | - | NPPES |
| 2638006 | Medicaid | OH |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | 35-087325 (Ohio) | Secondary |
| 208M00000X | Hospitalist | 01078604A (Indiana) | Secondary |
| 207R00000X | Internal Medicine | 01078604A (Indiana) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Ascension St Vincent Anderson | Anderson, IN | Hospital |
| Indiana University Health Bloomington Hospital | Bloomington, IN | Hospital |
| Ascension St Vincent Carmel | Carmel, IN | Hospital |
| Ascension St Vincent Fishers | Fishers, IN | Hospital |
| Ascension St Vincent Kokomo | Kokomo, IN | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Indiana University Health Southern Indiana Physicians Llc | 6204748197 | 449 |
| St Vincent Medical Group Inc | 7012047640 | 625 |
News Archive
Zafgen, Inc., a pharmaceutical company pioneering novel obesity therapeutics to help the body regain and sustain a lean, healthy state by targeting imbalances in fat metabolism, today announced new data from a Phase 1b study of ZGN-433, a selective methionine aminopeptidase 2 inhibitor (MetAP2), which showed a significant improvement in cardiovascular risk markers in severely obese subjects.
Published today in the British Medical Journal Open, the longitudinal study of more than 60,000 Australians aged 45 years and above measured participants fruit and vegetable consumption, lifestyle factors and psychological distress at two time points, 2006-08 and 2010.
Zix Corporation, a leading provider of email data protection, announces that Wake Forest Baptist Medical Center has renewed its contract for Zix™ Email Encryption Services in a three-year agreement. A leading, fully integrated academic medical center, Wake Forest Baptist began using Zix Services in 2004 and continues to select ZixCorp based on its consistent leadership in email encryption and its dedication to ease of use.
Cerimon Pharmaceuticals, Inc., announced today that it has acquired exclusive rights to develop and commercialize its once-daily topical diclofenac sodium patch in Europe, including most countries in the European Union, Turkey, Switzerland, Norway, the Balkan countries and Iceland. Terms of the agreement were not disclosed. Cerimon initially acquired the U.S. rights to develop and commercialize the patch formulation of diclofenac in 2005.
› Verified 9 days ago
| Entity Name | Indiana University Health Southern Indiana Physicians Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1013953983 PECOS PAC ID: 6204748197 Enrollment ID: O20040423000556 |
News Archive
Zafgen, Inc., a pharmaceutical company pioneering novel obesity therapeutics to help the body regain and sustain a lean, healthy state by targeting imbalances in fat metabolism, today announced new data from a Phase 1b study of ZGN-433, a selective methionine aminopeptidase 2 inhibitor (MetAP2), which showed a significant improvement in cardiovascular risk markers in severely obese subjects.
Published today in the British Medical Journal Open, the longitudinal study of more than 60,000 Australians aged 45 years and above measured participants fruit and vegetable consumption, lifestyle factors and psychological distress at two time points, 2006-08 and 2010.
Zix Corporation, a leading provider of email data protection, announces that Wake Forest Baptist Medical Center has renewed its contract for Zix™ Email Encryption Services in a three-year agreement. A leading, fully integrated academic medical center, Wake Forest Baptist began using Zix Services in 2004 and continues to select ZixCorp based on its consistent leadership in email encryption and its dedication to ease of use.
Cerimon Pharmaceuticals, Inc., announced today that it has acquired exclusive rights to develop and commercialize its once-daily topical diclofenac sodium patch in Europe, including most countries in the European Union, Turkey, Switzerland, Norway, the Balkan countries and Iceland. Terms of the agreement were not disclosed. Cerimon initially acquired the U.S. rights to develop and commercialize the patch formulation of diclofenac in 2005.
› Verified 9 days ago
| Entity Name | St Vincent Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1144513375 PECOS PAC ID: 7012047640 Enrollment ID: O20100609000045 |
News Archive
Zafgen, Inc., a pharmaceutical company pioneering novel obesity therapeutics to help the body regain and sustain a lean, healthy state by targeting imbalances in fat metabolism, today announced new data from a Phase 1b study of ZGN-433, a selective methionine aminopeptidase 2 inhibitor (MetAP2), which showed a significant improvement in cardiovascular risk markers in severely obese subjects.
Published today in the British Medical Journal Open, the longitudinal study of more than 60,000 Australians aged 45 years and above measured participants fruit and vegetable consumption, lifestyle factors and psychological distress at two time points, 2006-08 and 2010.
Zix Corporation, a leading provider of email data protection, announces that Wake Forest Baptist Medical Center has renewed its contract for Zix™ Email Encryption Services in a three-year agreement. A leading, fully integrated academic medical center, Wake Forest Baptist began using Zix Services in 2004 and continues to select ZixCorp based on its consistent leadership in email encryption and its dedication to ease of use.
Cerimon Pharmaceuticals, Inc., announced today that it has acquired exclusive rights to develop and commercialize its once-daily topical diclofenac sodium patch in Europe, including most countries in the European Union, Turkey, Switzerland, Norway, the Balkan countries and Iceland. Terms of the agreement were not disclosed. Cerimon initially acquired the U.S. rights to develop and commercialize the patch formulation of diclofenac in 2005.
› Verified 9 days ago
| Entity Name | Sound Physicians Of Indiana, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1528311149 PECOS PAC ID: 4981841780 Enrollment ID: O20130515000624 |
News Archive
Zafgen, Inc., a pharmaceutical company pioneering novel obesity therapeutics to help the body regain and sustain a lean, healthy state by targeting imbalances in fat metabolism, today announced new data from a Phase 1b study of ZGN-433, a selective methionine aminopeptidase 2 inhibitor (MetAP2), which showed a significant improvement in cardiovascular risk markers in severely obese subjects.
Published today in the British Medical Journal Open, the longitudinal study of more than 60,000 Australians aged 45 years and above measured participants fruit and vegetable consumption, lifestyle factors and psychological distress at two time points, 2006-08 and 2010.
Zix Corporation, a leading provider of email data protection, announces that Wake Forest Baptist Medical Center has renewed its contract for Zix™ Email Encryption Services in a three-year agreement. A leading, fully integrated academic medical center, Wake Forest Baptist began using Zix Services in 2004 and continues to select ZixCorp based on its consistent leadership in email encryption and its dedication to ease of use.
Cerimon Pharmaceuticals, Inc., announced today that it has acquired exclusive rights to develop and commercialize its once-daily topical diclofenac sodium patch in Europe, including most countries in the European Union, Turkey, Switzerland, Norway, the Balkan countries and Iceland. Terms of the agreement were not disclosed. Cerimon initially acquired the U.S. rights to develop and commercialize the patch formulation of diclofenac in 2005.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Bahadur Shah, MD 250 W 96th St # 520, Indianapolis, IN 46260-1316 Ph: () - | Bahadur Shah, MD 2015 Jackson St, Anderson, IN 46016 Ph: (765) 649-2511 |
News Archive
Zafgen, Inc., a pharmaceutical company pioneering novel obesity therapeutics to help the body regain and sustain a lean, healthy state by targeting imbalances in fat metabolism, today announced new data from a Phase 1b study of ZGN-433, a selective methionine aminopeptidase 2 inhibitor (MetAP2), which showed a significant improvement in cardiovascular risk markers in severely obese subjects.
Published today in the British Medical Journal Open, the longitudinal study of more than 60,000 Australians aged 45 years and above measured participants fruit and vegetable consumption, lifestyle factors and psychological distress at two time points, 2006-08 and 2010.
Zix Corporation, a leading provider of email data protection, announces that Wake Forest Baptist Medical Center has renewed its contract for Zix™ Email Encryption Services in a three-year agreement. A leading, fully integrated academic medical center, Wake Forest Baptist began using Zix Services in 2004 and continues to select ZixCorp based on its consistent leadership in email encryption and its dedication to ease of use.
Cerimon Pharmaceuticals, Inc., announced today that it has acquired exclusive rights to develop and commercialize its once-daily topical diclofenac sodium patch in Europe, including most countries in the European Union, Turkey, Switzerland, Norway, the Balkan countries and Iceland. Terms of the agreement were not disclosed. Cerimon initially acquired the U.S. rights to develop and commercialize the patch formulation of diclofenac in 2005.
› Verified 9 days ago
Mark Randall Jennings, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 2015 Jackson St, Anderson, IN 46016 Phone: 765-649-2511 | |
Dr. Dalwinderpal Singh Samra, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 1547 Ohio Ave., Anderson, IN 46016 Phone: 609-694-8566 | |
Ubaidullah Sharief, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 2020 Meridian St Ste 100, Anderson, IN 46016 Phone: 765-646-8509 | |
Adam L Greene, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 141 W 22nd St Ste 109, Anderson, IN 46016 Phone: 765-646-8538 | |
Chad Michael Feldman, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 141 W 22nd St Ste 109, Anderson, IN 46016 Phone: 765-646-8538 | |
Dr. Edgardo Manuel Flores Anticona, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 2101 Jackson St Ste 110, Anderson, IN 46016 Phone: 765-643-6012 Fax: 765-646-9054 | |
Kristine M Rea, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 141 W 22nd St Ste 212, Anderson, IN 46016 Phone: 765-648-4138 |